BULLFROG AI HOLDINGS, INC. Adjustments to Additional Paid in Capital, Other
BULLFROG AI HOLDINGS, INC. (BFRG) reported Adjustments to Additional Paid in Capital, Other of $9.22 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-29.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2024-03-29
- BULLFROG AI HOLDINGS, INC. adjustments to additional paid in capital, other for the quarter ending 2022-09-30 was $2.25K.
- BULLFROG AI HOLDINGS, INC. adjustments to additional paid in capital, other for the quarter ending 2022-06-30 was $2.36K.
- BULLFROG AI HOLDINGS, INC. adjustments to additional paid in capital, other for the quarter ending 2022-03-31 was $2.36K.
- BULLFROG AI HOLDINGS, INC. adjustments to additional paid in capital, other for fiscal 2022 was $9.22K, a 103.15% increase from fiscal 2021.
- BULLFROG AI HOLDINGS, INC. adjustments to additional paid in capital, other for fiscal 2021 was $4.54K.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 6 month | Adjustments to Additional Paid in Capital, Other 9 month | Adjustments to Additional Paid in Capital, Other 12 month |
|---|---|---|---|---|
| 2022-12-31 | $9.22K 10-K · filed 2024-03-29 | |||
| 2022-09-30 | $2.25K 10-Q · filed 2023-11-14 | $4.61K derived: sum of 2 quarters · filed 2023-11-14 | $6.97K derived: sum of 3 quarters · filed 2023-11-14 | |
| 2022-06-30 | $2.36K 10-Q · filed 2023-11-14 | $4.72K derived: sum of 2 quarters · filed 2023-11-14 | ||
| 2022-03-31 | $2.36K 10-Q · filed 2023-11-14 | |||
| 2021-12-31 | $4.54K 10-K · filed 2023-04-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B |